Zoetis (+0.72%) ZTS

Sector: Health Care | Focus: Pharmaceuticals
HQ: Parsippany, New Jersey
Closing Prices Chart
Financial Risks

Zoetis faces risks from global economic conditions, including regional conflicts, inflation, and supply chain disruptions. Foreign exchange rate fluctuations significantly impact revenue and earnings, particularly in emerging markets. Product liability lawsuits, antitrust litigation, and government investigations pose potential financial losses. Uncertain tax positions, including audits by the IRS, could result in substantial additional tax liabilities. The company's substantial debt and related covenants also present risks.

Financial Upside

Zoetis' revenue increased in both the three and nine-month periods, driven by price increases, new product sales, and growth in key product lines. The company's diversified product portfolio and global operations provide stability. Acquisitions, while carrying integration costs, potentially expand product offerings and market reach. The divestiture of certain assets, while carrying restructuring costs, could generate proceeds.

← Back to Index